|
Project description |
|
| Title: | MoleMate™ UK Trial: The management of suspicious pigmented lesions in primary care. |
| Short Title: | MoleMate UK Trial. |
| Principal Research Question: | To assess whether using the MoleMate system (SIAscopy plus an algorithm specifically developed for primary care) will lead to more accurate diagnosis of suspicious pigmented lesions in primary care. |
| Start date: | 1 January 2007 |
| End date: | 31 December 2010 |
| Ethics Approval: | Approval received from the Cambridgeshire 2 Research Ethics Committee on the 26th October 2007. REC Reference Number: 07/H0308/167. |
|
Trial Number: |
|
|
Funding Information |
|
| Funding organisation name: | NHS National Institute for Health Research: School for Primary Care Research |
| Funding amount: | £304,487 |
| Additional support: | The MoleMate systems for the trial were kindly supplied by Astron Clinica. In August 2009, Astron Clinica Ltd was taken over by Biocompatibles International plc, by BTG (British Technology Group) in January 2011 and in June 2011 by MedX Health. |
|
Acknowledgements |
|
| MoleMate, SIAscopy, SIAscan and SIAscope are trademarks of MedX Health. | |